Clinical Trials · NCT01005784

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Aristotle University Of Thessaloniki
Enrollment
146
Start date
Jun 2005
Locations
1 site, Greece
Primary endpoint
Luteinizing hormone rise
View Gonadorelin compound reference